This page is for health professionals only.

NO
I AM NOT
A HEALTHCARE PROFESSIONAL.
Aripiprazole-Associated Tardive Dyskinesia: A Case Report
PDF
Cite
Share
Request
Case Report
VOLUME: 32 ISSUE: 2
P: 125 - 127
July 2025

Aripiprazole-Associated Tardive Dyskinesia: A Case Report

Turk J Child Adolesc Ment Health 2025;32(2):125-127
1. Dokuz Eylül Üniversitesi Tıp Fakültesi, Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Anabilim Dalı, İzmir, Türkiye
2. Sahlgrenska Üniversitesi, Queen Silvia Çocuk Hastanesi, Çocuk ve Ergen Psikiyatrisi Kliniği, Göteborg, İsveç
No information available.
No information available
Received Date: 03.01.2023
Accepted Date: 16.05.2024
Online Date: 14.07.2025
Publish Date: 14.07.2025
PDF
Cite
Share
Request

ABSTRACT

Tardive dyskinesia is an abnormal, involuntary, and repetitive movement disorder that occurs during treatment with antipsychotic drugs. Although its pathophysiology has not been fully elucidated, it is usually a late-onset and chronic condition that significantly affects quality of life. A small number of cases of tardive dyskinesia have been reported in patients treated with aripiprazole as antipsychotic medication. The majority of case reports involve adult patients, while reports of tardive dyskinesia following aripiprazole treatment in children and adolescents remain limited. In this case report, the side effect of tardive dyskinesia, which developed following long-term aripiprazole use and regressed rapidly after drug discontinuation, was discussed in a 16-year-old patient who was follow-up with the diagnoses of major depressive disorder and dissociative disorder.

Keywords:
Antipsychotic, aripiprazole, child and adolescent, tardive dyskinesia, side effect